Dova Pharmaceuticals Inc (DOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -5,424 | -27,190 | -19,590 | -12,416 |
| Accounts payable and accrued liabilities | -31 | N/A | 13 | 17 |
| Other Working Capital | -196 | 7,560 | 189 | 423 |
| Other Operating Activity | 4,298 | 18,650 | 18,728 | 11,971 |
| Operating Cash Flow | $-1,353 | $-980 | $-660 | $-5 |
| Cash Flows From Investing Activities | ||||
| Investing Cash Flow | $N/A | $0 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Other Financing Activity | -711 | 29,690 | 10,696 | 187 |
| Financing Cash Flow | $-711 | $29,690 | $10,696 | $187 |
| Beginning Cash Position | 28,709 | 0 | N/A | N/A |
| End Cash Position | 26,645 | 28,700 | 10,036 | 182 |
| Net Cash Flow | $-2,064 | $28,700 | $10,036 | $182 |
| Free Cash Flow | ||||
| Operating Cash Flow | -1,353 | -980 | -660 | -5 |
| Free Cash Flow | -1,353 | -980 | -660 | -5 |